GI
RDHL

GAMMA Investing’s Redhill Biopharma RDHL Stock Holding History

GAMMA Investing’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.88K Buy
6,957
+273
+4% +$252 ﹤0.01% 3406
2026
Q1 		$4.98K Buy
6,684
+1,856
+38% +$1.96K ﹤0.01% 3364
2025
Q4 		$4.97K Buy
4,828
+4,693
+3,476% +$6.31K ﹤0.01% 3274
2025
Q3 		$293 Sell
135
-1,926
-93% -$3.14K ﹤0.01% 3767
2025
Q2 		$4K Sell
2,061
-1,507
-42% -$3.07K ﹤0.01% 3206
2025
Q1 		$9.49K Sell
3,568
-1,521
-30% -$7.09K ﹤0.01% 2766
2024
Q4 		$31.6K Buy
+5,089
New +$38.9K ﹤0.01% 2009

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return

GAMMA Investing's RDHL Position: Q2 2026 in Review

GAMMA Investing increased its Redhill Biopharma (RDHL) stake by 4.1% in Q2 2026, buying an estimated $252 and bringing the position to 6,957 shares worth $5.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3406.

GAMMA Investing first reported a position in RDHL in Q4 2024 and has held it in 7 quarters since. The position peaked at $31.6K in Q4 2024. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • GAMMA Investing held 6,957 shares of Redhill Biopharma worth $5.88K as of Q2 2026.
  • GAMMA Investing bought 273 Redhill Biopharma shares in Q2 2026, an estimated $252.
  • Redhill Biopharma made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3406 holding.
  • GAMMA Investing first reported a position in Redhill Biopharma in Q4 2024 and has held it in 7 quarters since.
  • GAMMA Investing's Redhill Biopharma position peaked at $31.6K in Q4 2024.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.